Skip to content
10-Q

Quarterly Report

FV Pharma International Corp.

0001565220-13-000012

← back to feed
Filed
Dec 11, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Oct 31, 2013 8.36M sh
Operating Cash Flow Q3 2013 · Oct 31, 2013 −$31.08K
Operating Cash Flow Q3 2013 · Oct 31, 2013 −$29.32K
Operating Cash Flow Q3 2013 · Oct 31, 2012 −$141
Total Liabilities Q3 2013 · Oct 31, 2013 $2.29K
Total Liabilities Q3 2013 · Jan 31, 2013 $552
Current Assets Q3 2013 · Oct 31, 2013 $6.81K
Current Assets Q3 2013 · Jan 31, 2013 $31.56K
Total Assets Q3 2013 · Oct 31, 2013 $6.81K
Total Assets Q3 2013 · Jan 31, 2013 $31.56K
Eps Basic Q3 2013 · Oct 31, 2013 $0.00
Eps Basic Q3 2013 · Oct 31, 2012 $0.00
Eps Basic Q3 2013 · Oct 31, 2012 $0.00
Sga Expense Q3 2013 · Oct 31, 2013 $27.46K
Sga Expense Q3 2013 · Oct 31, 2012 $98
Sga Expense Q3 2013 · Oct 31, 2012 $141
Net Income Q3 2013 · Oct 31, 2013 −$25.08K
Net Income Q3 2013 · Oct 31, 2012 −$98
Net Income Q3 2013 · Oct 31, 2012 −$141
Operating Income Q3 2013 · Oct 31, 2013 −$14.66K
Operating Income Q3 2013 · Oct 31, 2013 −$26.48K
Operating Income Q3 2013 · Oct 31, 2013 −$24.99K
Operating Income Q3 2013 · Oct 31, 2012 −$98
Operating Income Q3 2013 · Oct 31, 2012 −$141
Revenue Q3 2013 · Oct 31, 2013 $2.48K
Cash And Equivalents Q3 2013 · Oct 31, 2012 $7.06K